Rafarma Pharmaceuticals (RAFA) Revenue
Rafarma Pharmaceuticals Revenue
Rafarma Pharmaceuticals had a revenue of 302.00K in the quarter ending Jun 30, 2026, with -1.95%. This bring the company's revenue in the last twelve months to 610.00K, Increased 1.16%. In the fiscal year ending Dec 31, 2025, Rafarma Pharmaceuticals had annual revenue of 9.18M with 1.09% growth.
- Revenue (ttm)
- 610.00K
- Revenue Growth
- ―
- P/S Ratio
- 0.16
- Revenue/Employee
- $13,110
- Employees
- 700
- Market Cap
- $1.45M
Revenue Chart
Rafarma Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.18M | 99.00K | 1.09% |
| Dec 31, 2024 | 9.08M | -1.06M | -10.43% |
| Dec 31, 2023 | 10.13M | -54.18M | -84.24% |
| Dec 31, 2022 | 64.31M | -13.10M | -16.92% |
| Dec 31, 2021 | 77.41M | 2.68M | 3.59% |
| Dec 31, 2020 | 74.73M | 63.29M | 553.15% |
| Jan 31, 2020 | 11.44M | 11.29M | 7672.64% |
| Jan 31, 2019 | 147.20K | 22.11K | 17.67% |
| Jan 31, 2018 | 125.10K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.